We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Insulin Detemir and Waist Circumference

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00714844
First Posted: July 14, 2008
Last Update Posted: July 14, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Roma La Sapienza
July 7, 2008
July 14, 2008
July 14, 2008
January 2007
October 2007   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Insulin Detemir and Waist Circumference
Waist Circumference Reduction After Insulin Detemir Treatment in Type 2 Diabetes Patients Previously Treated With NPH Insulin
The purpose of the study is to investigate the weight-sparing effect of detemir and assess glycemic control and treatment satisfaction when switching from NPH to detemir, to improve metabolic control.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
Type 2 diabetic patients accessing the Diabetologic Centre
Type 2 Diabetes
Not Provided
Not Provided
Mandosi E, Fallarino M, Rossetti M, Gatti A, Morano S. Waist circumference reduction after insulin detemir therapy in type 2 diabetes patients previously treated with NPH. Diabetes Res Clin Pract. 2009 May;84(2):e18-20. doi: 10.1016/j.diabres.2009.02.006. Epub 2009 Mar 17.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
October 2007
October 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Duration of type 2 diabetes for at least 12 months
  • BMI <40 kg/m2
  • HbA1c >7.5%
  • Requiring basal insulin replacement and previously treated with NPH insulin
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00714844
PolUmbI-DptSClin-Det1
No
Not Provided
Not Provided
Susanna Morano, University of Roma La Sapienza, Policlinico Umberto I, Dpt Scienze Cliniche
University of Roma La Sapienza
Not Provided
Not Provided
University of Roma La Sapienza
April 2008